[go: up one dir, main page]

Kohno et al., 1984 - Google Patents

Kidney plasminogen activator: a precursor form of human urokinase with high fibrin affinity

Kohno et al., 1984

View PDF
Document ID
12421011837676994088
Author
Kohno T
Hopper P
Lillquist J
Suddith R
Greenlee R
Moir D
Publication year
Publication venue
Bio/Technology

External Links

Snippet

A systematic screen of human kidney tissue samples has resulted in the establishment of a permanent cell line, TCL-598, which produces and secretes into the medium milligrams per liter quantities of a urokinase-like plasminogen activator. Analysis of the properties of this …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions

Similar Documents

Publication Publication Date Title
Kohno et al. Kidney plasminogen activator: a precursor form of human urokinase with high fibrin affinity
Wun et al. A proenzyme form of human urokinase.
Sottrup-Jensen et al. Amino-acid sequence of activation cleavage site in plasminogen: homology with" pro" part of prothrombin.
Stump et al. Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator.
Pannell et al. Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect
Zamarron et al. Biological and thrombolytic properties of proenzyme and active forms of human urokinase–I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technology
Husain et al. Purification and partial characterization of a single-chain high-molecular-weight form of urokinase from human urine
Kohnert et al. Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022
Levin et al. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators.
Ichinose et al. Localization of the binding site of tissue-type plasminogen activator to fibrin.
Allen et al. Isolation and properties of human vascular plasminogen activator
Marcotte et al. The matrix metalloproteinase pump-1 catalyzes formation of low molecular weight (pro) urokinase in cultures of normal human kidney cells.
Loskutoff et al. Interactions between fibrin and the plasminogen activators produced by cultured endothelial cells
Nielsen et al. Plasminogen activators catalyse conversion of inhibitor from fibrosarcoma cells to an inactive form with a lower apparent molecular mass
Winkler et al. Purification and characterization of recombinant single-chain urokinase produced in Escherichia coli
Hubbard et al. Vitamin K-dependent carboxylase: affinity purification from bovine liver by using a synthetic propeptide containing the gamma-carboxylation recognition site.
Booth et al. Plasminogen activator inhibitor from human endothelial cells: purification and partial characterization
Dahl et al. Enhancement of urokinase-induced plasminogen activation by the cationic protein of human eosinophil granulocytes
Sumi et al. A functionally active heavy chain derived from human high molecular weight urokinase.
Pierard et al. Mutant and chimeric recombinant plasminogen activators. Production in eukaryotic cells and preliminary characterization.
Gonias et al. Reaction of human. alpha. 2-macroglobulin half-molecules with plasmin as a probe of protease binding site structure
Sumi et al. Urokinase-like plasminogen activator increased in plasma after alcohol drinking
Harvey et al. Urokinase-like plasminogen activators of unusually high molecular weight secreted by a cell line derived from a human lung cancer case.
Lijnen et al. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
Lijnen et al. Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA)-studies with active site mutagenized plasminogen and plasmin resistant t-PA